Snapshot from Jul 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / ADMA Biologics securities class action
Regulatory class action

ADMA Biologics securities class action

Analysis based on 6 articles · First reported Jul 20, 2026 · Last updated Jul 24, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit may negatively impact ADMA Biologics' stock price and investor confidence. The allegations of channel stuffing and inadequate internal controls could lead to regulatory scrutiny and financial penalties.

Biotechnology
Event Summary

Rosen Law Firm reminds investors of the August 10, 2026 lead plaintiff deadline in a securities class action against ADMA Biologics, Inc. (NASDAQ: ADMA). The lawsuit, first filed by Rosen Law Firm, alleges that ADMA Biologics made materially false and misleading statements between August 9, 2024 and March 25, 2026, including failure to disclose an undisclosed related party transaction, use of channel stuffing to inflate revenue, and lack of adequate internal controls. Investors who purchased ADMA securities during the Class Period may be eligible for compensation.

Key Actions
80 Rosen Law Firm announced investigation ADMA Biologics
Entities Involved
stock
ADMA Biologics
ADMA Biologics is the defendant in the securities class action, facing allegations of fraudulent financial reporting and inadequate internal controls, which could result in financial damages and reputational harm.
Importance 100.0 Sentiment -50.0
priv
Rosen Law Firm
Rosen Law Firm is the plaintiff's counsel leading the class action, seeking compensation for investors; the firm benefits from increased visibility and potential legal fees.
Importance 60.0 Sentiment 10.0
per
Lawrence Rosen
Lawrence Rosen is a partner at Rosen Law Firm and is listed as a contact for the class action; his role is primarily administrative.
Importance 20.0 Sentiment 5.0
per
Philip Kim
Philip Kim is an attorney at Rosen Law Firm and is listed as a contact for the class action; his role is primarily administrative.
Importance 20.0 Sentiment 5.0
Relationships
ADMA Biologics related ↔ Rosen Law Firm
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm related ↔ Philip Kim
Lawrence Rosen managing partner ↔ Philip Kim Lawrence Rosen is the founder and managing partner of Rosen Law Firm, where Philip Kim is a partner, and they actively c
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.